Company profile
Neuralink
Neuralink develops fully implantable brain-computer interfaces for people with unmet medical needs. Its technology is designed to let users control compute...
Facts
- Segment
- SURGICAL
- Country
- US
- Headquarters
- Fremont
- Founded
- 2016
- Website
- https://neuralink.com/
About Neuralink
The N1 implant records neural activity through 1,024 electrodes distributed across 64 flexible threads. Neuralink’s R1 surgical robot inserts those threads into targeted areas of the brain while avoiding surface blood vessels, after which the implant communicates wirelessly with an external computer.
Software decodes patterns associated with intended movement and converts them into cursor, keyboard or device-control commands. Neuralink’s PRIME study evaluates computer control for people with paralysis, while a separate feasibility study extends the interface toward controlling an assistive robotic arm.
Market context
DEVELOPMENT
Summary
Type: BCI company
Core: R1 robot
Function: Surgery
Audience: Healthcare providers
Research, Articles and recent verified events
- Neuralink details surgical robot automation for implant procedure — 2026-04-30
- Neuralink participant controls robotic arm through CONVOY study — 2026-04-29
- Neuralink targets high-volume implant production and automated surgical procedures — 2026-01-01
- Neuralink raises $650 million Series E to expand clinical trials and BCI development — 2025-06-02
- Neuralink launches CONVOY feasibility study for robotic arm control — 2024-11-24
- Neuralink receives Health Canada approval for CAN-PRIME Study — 2024-11-01
- Neuralink receives FDA Breakthrough Device Designation for Blindsight — 2024-09-01
- Neuralink reports PRIME Study progress after first human implant — 2024-04-12